The AccuPower® BCI Blood Screening Kit is an in vitro diagnostic kit designed for the simultaneous detection of human immunodeficincy virus type 1 (HIV-1) RNA, hepatitis C virus (HCV) RNA and hepatitis B virus (HBV) DNA in human blood through real-time PCR using ExiStation™ ™ MDx System. First, the kit is intended for use in testing plasma and serum specimens to screen organ donors when specimens are obtained while the donor’s heart is still beating, and in testing blood specimens from cadaveric (non-hear-beating) donors. Secondly, the assay is not intended for use on cord blood specimens from mothers with recent birth. Third, the assay is intended to use indovidual samples from living adult donors of whole blood, blood components, plasma, other living donors and heart-beating organ donors, and from individual blood specimens from cadaveric (non-heart-beating) donors. Target – Human immunodeficiency virus type 1, 2, Hepatitis C virus, Hepatitis B virus Sample type – Serum, EDTA-plasma Instrument – ExiStation™ The AccuPower® BCI Blood Screening Kit provides : • Highly sensitive detection of HBV, HIV-1, and HCV The LoD for HIV-1 : 100 IU/mL, HCV : 100 IU/mL, and HBV : 50 IU/mL • Distinc detection of each target, HBV, HCV, and HIV-1, by ExiStation™ MDx System • High reability through Internal Positive Control and Positive Control • One-Step real-time Rt-PCR reaction using RocketScript™ Reverse Transcriptase and Dual-Hotstart ™technology